波动性精神状态评估的初步研究:一种新型神经重症患者谵妄筛查工具
本研究为单中心前瞻性初步研究,纳入40例脑出血患者,住院期间每日进行谵妄评估,以《精神疾病诊断与统计手册》第五版标准作为参考标准,由临床护士在接受简短一对一培训后配对完成FMSE评估。在308个非昏迷配对评估日中,208天(68%)被专家评定为谵妄日;FMSE评分≥1的敏感度86%、特异度73%,评分≥2的敏感度68%、特异度82%,在失语和觉醒度下降患者中准确度仍较高。作者结论认为FMSE在检测谵妄方面取得了高敏感度和特异度,后续将在更大、更多样化的神经重症队列中使用评分≥1作为「可能」谵妄、≥2作为「很可能」谵妄进行验证研究。
要点
- 在脑出血患者非昏迷日配对评估中,FMSE评分≥1筛查谵妄的敏感度86%、特异度73%。
- FMSE评分≥2筛查谵妄的敏感度68%、特异度82%。
- 失语患者中FMSE评分≥1敏感度83%、特异度77%,评分≥2敏感度68%、特异度85%。
- 觉醒度下降患者中FMSE评分≥1敏感度80%、特异度100%,评分≥2敏感度73%、特异度100%。
- 作者计划后续验证研究以评分≥1为「可能」谵妄、≥2为「很可能」谵妄。
适用人群与场景
- 单中心前瞻性初步队列,纳入40例脑出血患者,住院期间每日进行谵妄评估;平均年龄71.1±12.2岁,55%为男性,美国国立卫生研究院卒中量表评分中位数16.5(四分位距12-20)。
- FMSE准确度分析仅纳入非昏迷患者。
诊断标准与关键阈值
- 参考标准为《精神疾病诊断与统计手册》第五版谵妄标准,由专家每日下午根据床旁评估及前24小时临床数据评定。
- FMSE评分≥1定义为「可能」谵妄,评分≥2定义为「很可能」谵妄(作者计划在后续验证研究中使用)。
研究设计与关键结果
- 单中心前瞻性初步研究,纳入40例脑出血患者,85%(n=34)在住院期间发生谵妄。
- 共308个非昏迷配对评估日,其中208天(68%)被专家评定为谵妄日。
- 与专家评定相比,FMSE评分≥1的敏感度86%、特异度73%;评分≥2的敏感度68%、特异度82%。
- 失语患者中,FMSE评分≥1敏感度83%、特异度77%;评分≥2敏感度68%、特异度85%。
- 觉醒度下降患者中,FMSE评分≥1敏感度80%、特异度100%;评分≥2敏感度73%、特异度100%。
证据类型、等级与局限
- 证据类型:单中心前瞻性初步研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为FMSE在检测谵妄方面取得了高敏感度和特异度;后续将在更大、更多样化的神经重症患者队列中验证,评分≥1作为「可能」谵妄、≥2作为「很可能」谵妄。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Delirium occurs frequently in patients with stroke and neurocritical illness but is often underrecognized. We developed a novel delirium screening tool designed specifically for neurocritical care patients called the fluctuating mental status evaluation (FMSE) and aimed to test its usability and accuracy in a representative cohort of patients with intracerebral hemorrhage (ICH).
METHODS: We performed a single-center prospective study in a pilot cohort of patients with ICH who had daily delirium assessments throughout their admission. Reference-standard expert ratings were performed each afternoon using criteria from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and were derived from bedside assessments and clinical data from the preceding 24 h. Paired FMSE assessments were performed by patients' clinical nurses after receiving brief one-on-one training from research staff. Nursing assessments were aggregated over 24-h periods (including day and night shifts), and accuracy of the FMSE was analyzed in patients who were not comatose to determine optimal scoring thresholds.
RESULTS: We enrolled 40 patients with ICH (mean age 71.1 ± 12.2, 55% male, median National Institutes of Health Stroke Scale score 16.5 [interquartile range 12-20]), of whom 85% (n = 34) experienced delirium during their hospitalization. Of 308 total coma-free days with paired assessments, 208 (68%) were rated by experts as days with delirium. Compared with expert ratings, FMSE scores ≥ 1 had 86% sensitivity and 73% specificity on a per-day basis, whereas FMSE scores ≥ 2 had 68% sensitivity and 82% specificity. Accuracy remained high in patients with aphasia (FMSE scores ≥ 1: 83% sensitivity, 77% specificity; FMSE scores ≥ 2: 68% sensitivity, 85% specificity) and decreased arousal (FMSE scores ≥ 1: 80% sensitivity, 100% specificity; FMSE scores ≥ 2: 73% sensitivity, 100% specificity).
CONCLUSIONS: In this pilot study, the FMSE achieved a high sensitivity and specificity in detecting delirium. Follow-up validation studies in a larger more diverse cohort of neurocritical care patients will use score cutoffs of ≥ 1 as "possible" delirium and ≥ 2 as "probable" delirium.
参考来源
- Reznik ME, Margolis SA, Moody S, et al. A Pilot Study of the Fluctuating Mental Status Evaluation: A Novel Delirium Screening Tool for Neurocritical Care Patients. Neurocrit Care. 2022. PMID: 36241773. doi:10.1007/s12028-022-01612-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。